Plasma protoporphyrin IX following administration of 5-aminolevulinic acid as a potential tumor marker.

Ota, Urara; Fukuhara, Hideo; Ishizuka, Masahiro; Abe, Fuminori; Kawada, Chiaki; Tamura, Kenji; Tanaka, Tohru; Inoue, Keiji; Ogura, Shun-Ichiro; Shuin, Taro

Ota, Urara; Fukuhara, Hideo; Ishizuka, Masahiro; Abe, Fuminori; Kawada, Chiaki; Tamura, Kenji; Tanaka, Tohru; Inoue, Keiji; Ogura, Shun-Ichiro; Shuin, Taro.

Afiliação

Ota U; SBI Pharmaceuticals Co., Ltd., Izumi Garden Tower 20F, 1-6-1, Tokyo 106-6020, Japan.
Fukuhara H; Department of Urology, Kochi Medical School, Nankoku, Kochi 783-8505, Japan.
Ishizuka M; SBI Pharmaceuticals Co., Ltd., Izumi Garden Tower 20F, 1-6-1, Tokyo 106-6020, Japan.
Abe F; SBI Pharmaceuticals Co., Ltd., Izumi Garden Tower 20F, 1-6-1, Tokyo 106-6020, Japan.
Kawada C; Department of Urology, Kochi Medical School, Nankoku, Kochi 783-8505, Japan.
Tamura K; Department of Urology, Kochi Medical School, Nankoku, Kochi 783-8505, Japan.
Tanaka T; SBI Pharmaceuticals Co., Ltd., Izumi Garden Tower 20F, 1-6-1, Tokyo 106-6020, Japan.
Inoue K; Department of Urology, Kochi Medical School, Nankoku, Kochi 783-8505, Japan.
Ogura SI; Department of Bioengineering, Graduate School of Bioscience and Biotechnology, Tokyo Institute of Technology, Yokohama, Kanagawa 226-8501, Japan.
Shuin T; Department of Urology, Kochi Medical School, Nankoku, Kochi 783-8505, Japan.

Mol Clin Oncol ; 3(4): 797-801, 2015 Jul.

Article em En | MEDLINE | ID: mdl-26171183

Palavras-chave

5-aminolevulinic acid; plasma; protoporphyrin IX; tumor marker

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Mol Clin Oncol Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google